title: The expression ratio of Map7/B2M is prognostic for survival in patients with stage II colon cancer.
abstract: Colorectal cancer (CRC) is the second most frequent cause of cancer-related death in the United States. To determine whether certain molecular markers might be prognostic for survival, we measured by quantitative real-time RT-PCR the expression levels of 15 previously studied genes that are known to be up-regulated or down-regulated in the progression of epithelial cancers. The tumor samples were extracted from formalin-fixed paraffin-embedded primary tissues derived from patients with Stage II CRC who developed disease recurrence within two years (n=10), or were disease-free for at least 4 years (n=12). We were able to determine, by AUC curve analysis, that the ratio of microtubule associated protein 7 (Map7)/B2M was predictive of outcome in our sample set. Further, using Kaplan-Meier survival analysis, we observed significantly different curves as a function of marker positivity for the Map7/B2M (p=0.0001; HR=11) expression ratio. This suggests that the expression ratio of Map7/B2M may serve as a valuable prognostic marker in patients with Stage II colon cancer, and potentially guide therapeutic decision making.
authors.affiliation: Department of Surgery, Medical University of South Carolina, Charleston, SC 29425, USA.
authors.forename: Craig
authors.initials: C
authors.lastname: Blum
authors.forename: Amanda
authors.initials: A
authors.lastname: Graham
authors.forename: Matt
authors.initials: M
authors.lastname: Yousefzadeh
authors.forename: Jessica
authors.initials: J
authors.lastname: Shrout
authors.forename: Katie
authors.initials: K
authors.lastname: Benjamin
authors.forename: Murli
authors.initials: M
authors.lastname: Krishna
authors.forename: Raza
authors.initials: R
authors.lastname: Hoda
authors.forename: Rana
authors.initials: R
authors.lastname: Hoda
authors.forename: David J
authors.initials: DJ
authors.lastname: Cole
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Garrett-Mayer
authors.forename: Carolyn
authors.initials: C
authors.lastname: Reed
authors.forename: Michael
authors.initials: M
authors.lastname: Wallace
authors.forename: Michael
authors.initials: M
authors.lastname: Mitas
mesh_terms: D000230:Adenocarcinoma / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D000368:Aged; D000369:Aged, 80 and over; D019540:Area Under Curve; D014408:Biomarkers, Tumor / Q000032:analysis*; D003110:Colonic Neoplasms / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D005260:Female; D015870:Gene Expression; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008869:Microtubule-Associated Proteins / Q000096:biosynthesis* / Q000235:genetics; D009367:Neoplasm Staging; D011379:Prognosis; D012372:ROC Curve; D020133:Reverse Transcriptase Polymerase Chain Reaction; D001613:beta 2-Microglobulin / Q000096:biosynthesis* / Q000235:genetics
chemical_list: D014408:Biomarkers, Tumor; D008869:Microtubule-Associated Proteins; D001613:beta 2-Microglobulin